{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:19:58Z","timestamp":1790504398222,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA15135"],"award-info":[{"award-number":["CA15135"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015520","name":"Department of Education and Knowledge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.cbi.2019.108775","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T02:09:36Z","timestamp":1564452576000},"page":"108775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice"],"prefix":"10.1016","volume":"312","author":[{"given":"Nermin","family":"Eissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh","family":"Azimullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrilla","family":"Jayaprakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Jayaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreesh K.","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Beiram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"\u0141a\u017cewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kie\u0107-Kononowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassem","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.108775_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116363","article-title":"Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid","volume":"10","author":"Baronio","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2019.108775_bib2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/jcpp.12864","article-title":"Secular changes in the symptom level of clinically diagnosed autism","volume":"59","author":"Arvidsson","year":"2018","journal-title":"JCPP (J. Child Psychol. Psychiatry)"},{"key":"10.1016\/j.cbi.2019.108775_bib3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","article-title":"Animal models of neuropsychiatric disorders","volume":"13","author":"Nestler","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cbi.2019.108775_bib4","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1007\/s10803-018-3568-z","article-title":"State-level trends in the prevalence of autism spectrum disorder (ASD) from 2000 to 2012: a reanalysis of findings from the autism and developmental disabilities network","volume":"48","author":"Sheldrick","year":"2018","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.cbi.2019.108775_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.2017.17812","article-title":"Prevalence of autism spectrum disorder among US children and adolescents, 2014-2016","volume":"319","author":"Xu","year":"2018","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.cbi.2019.108775_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.cbi.2019.108775_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/138955707780059817","article-title":"Recent advances in the development of hybrid molecules\/designed multiple compounds with antiamnesic properties","volume":"7","author":"Decker","year":"2007","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.cbi.2019.108775_bib8","first-page":"27","article-title":"Environmental factors influencing the risk of autism","volume":"22","author":"Karimi","year":"2017","journal-title":"J.\u00a0Res. Med. Sci."},{"key":"10.1016\/j.cbi.2019.108775_bib9","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.2174\/1381612821666150605105325","article-title":"Do Histamine receptor 3 antagonists have a place in the therapy for schizophrenia?","volume":"21","author":"Ellenbroek","year":"2015","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.cbi.2019.108775_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ajmg.a.36847","article-title":"Analysis of CHRNA7 rare variants in autism spectrum disorder susceptibility","volume":"167A","author":"Bacchelli","year":"2015","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.cbi.2019.108775_bib11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/14656566.2017.1308483","article-title":"Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline","volume":"18","author":"Hellings","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.cbi.2019.108775_bib12","doi-asserted-by":"crossref","first-page":"e999","DOI":"10.1038\/tp.2016.273","article-title":"Glutamatergic and GABAergic gene sets in attention-deficit\/hyperactivity disorder: association to overlapping traits in ADHD and autism","volume":"7","author":"Naaijen","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.cbi.2019.108775_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1603001","article-title":"Serotonin rebalances cortical tuning and behavior linked to autism symptoms in 15q11-13 CNV mice","volume":"3","author":"Nakai","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/j.cbi.2019.108775_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000478725","article-title":"A\u00a0dopamine hypothesis of autism spectrum disorder","volume":"39","author":"Paval","year":"2017","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.cbi.2019.108775_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.9758\/cpn.2017.15.3.229","article-title":"Low retinal dehydrogenase 1 (RALDH1) level in prepubertal boys with autism spectrum disorder: a possible link to dopamine dysfunction?","volume":"15","author":"Paval","year":"2017","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.cbi.2019.108775_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0074-7742(05)72015-8","article-title":"Psychological approaches to chronic catatonia-like deterioration in autism spectrum disorders","volume":"72","author":"Shah","year":"2006","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.cbi.2019.108775_bib17","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1007\/s00213-015-4058-z","article-title":"Modulation of social deficits and repetitive behaviors in a mouse model of autism: the role of the nicotinic cholinergic system","volume":"232","author":"Wang","year":"2015","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.cbi.2019.108775_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13229-017-0130-3","article-title":"Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism","volume":"8","author":"Chen","year":"2017","journal-title":"Mol. Autism."},{"key":"10.1016\/j.cbi.2019.108775_bib19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mehy.2017.01.015","article-title":"Infant acetylcholine, dopamine, and melatonin dysregulation: neonatal biomarkers and causal factors for ASD and ADHD phenotypes","volume":"100","author":"Hellmer","year":"2017","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.cbi.2019.108775_bib20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/pr.114.010249","article-title":"International union of basic and clinical pharmacology. XCVIII. Histamine receptors","volume":"67","author":"Panula","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cbi.2019.108775_bib21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0306-4522(97)00353-9","article-title":"Neuronal histamine deficit in Alzheimer's disease","volume":"82","author":"Panula","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.cbi.2019.108775_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuropharm.2015.11.005","article-title":"Cherry-picked ligands at histamine receptor subtypes","volume":"106","author":"Sadek","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cbi.2019.108775_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbr.2016.06.051","article-title":"Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases","volume":"312","author":"Sadek","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2019.108775_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/jm100064d","article-title":"Histamine H3 receptor as a drug discovery target","volume":"54","author":"Berlin","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.cbi.2019.108775_bib25","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.bcp.2007.01.002","article-title":"The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders","volume":"73","author":"Parmentier","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108775_bib26","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.tips.2011.01.003","article-title":"Histamine receptors in the CNS as targets for therapeutic intervention","volume":"32","author":"Passani","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2019.108775_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.05.001","article-title":"Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system","volume":"103","author":"Witkin","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2019.108775_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/jpet.110.166876","article-title":"Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease","volume":"336","author":"Brioni","year":"2011","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.108775_bib29","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/jpet.107.120311","article-title":"GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models","volume":"321","author":"Medhurst","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.108775_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062189","article-title":"The BTBR mouse model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex","volume":"8","author":"McTighe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2019.108775_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbr.2012.07.021","article-title":"The BTBR T+ tf\/J mouse model for autism spectrum disorders-in search of biomarkers","volume":"251","author":"Meyza","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2019.108775_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003067","article-title":"Unusual repertoire of vocalizations in the BTBR T+tf\/J mouse model of autism","volume":"3","author":"Scattoni","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2019.108775_bib33","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/npp.2009.201","article-title":"Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP","volume":"35","author":"Silverman","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cbi.2019.108775_bib34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","article-title":"Autism-like behavioral phenotypes in BTBR T+tf\/J mice","volume":"7","author":"McFarlane","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.cbi.2019.108775_bib35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijdevneu.2007.09.008","article-title":"Social deficits in BTBR T+tf\/J mice are unchanged by cross-fostering with C57BL\/6J mothers","volume":"25","author":"Yang","year":"2007","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.cbi.2019.108775_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-2999(93)90717-V","article-title":"Effect of thioperamide, a histamine H3 receptor antagonist, on electrically induced convulsions in mice","volume":"234","author":"Yokoyama","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108775_bib37","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1476-5381.2012.02093.x","article-title":"Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives","volume":"167","author":"Bhowmik","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108775_bib38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbr.2015.10.022","article-title":"The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats","volume":"297","author":"Khan","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2019.108775_bib39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.physbeh.2016.08.022","article-title":"The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats","volume":"165","author":"Sadek","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.cbi.2019.108775_bib40","doi-asserted-by":"crossref","first-page":"9911","DOI":"10.1016\/j.bmc.2008.10.029","article-title":"Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity","volume":"16","author":"Morini","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2019.108775_bib41","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/cns.12279","article-title":"Procognitive properties of drugs with single and multitargeting H3 receptor antagonist activities","volume":"20","author":"Nikolic","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cbi.2019.108775_bib42","first-page":"179","article-title":"Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents","volume":"61","author":"Petroianu","year":"2006","journal-title":"Die Pharmazie"},{"key":"10.1016\/j.cbi.2019.108775_bib43","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.bmc.2007.12.048","article-title":"Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling","volume":"16","author":"Bembenek","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2019.108775_bib44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuropharm.2015.10.023","article-title":"Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats","volume":"106","author":"Sadek","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cbi.2019.108775_bib45","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.neuron.2014.07.016","article-title":"The cerebellum, sensitive periods, and autism","volume":"83","author":"Wang","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.cbi.2019.108775_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12311-013-0511-x","article-title":"Consensus paper: the cerebellum's role in movement and cognition","volume":"13","author":"Koziol","year":"2014","journal-title":"Cerebellum"},{"key":"10.1016\/j.cbi.2019.108775_bib47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/aur.1338","article-title":"Altered peripheral and central inflammatory responses in a mouse model of autism","volume":"7","author":"Lucchina","year":"2014","journal-title":"Autism Res."},{"key":"10.1016\/j.cbi.2019.108775_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbi.2008.07.012","article-title":"Activation of the maternal immune system alters cerebellar development in the offspring","volume":"23","author":"Shi","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cbi.2019.108775_bib49","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3389\/fnhum.2014.00742","article-title":"The role of the hippocampus in flexible cognition and social behavior","volume":"8","author":"Rubin","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.cbi.2019.108775_bib50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/DDDT.S144730","article-title":"Anticonvulsant and reproductive toxicological studies of the imidazole-based histamine H3R antagonist 2-18 in mice","volume":"12","author":"Bastaki","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.cbi.2019.108775_bib51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S1461145711001714","article-title":"Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid","volume":"16","author":"Kataoka","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.cbi.2019.108775_bib52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pbb.2014.08.013","article-title":"Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism","volume":"126","author":"Takuma","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.cbi.2019.108775_bib53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bmc.2015.11.021","article-title":"Chlorophenoxy aminoalkyl derivatives as histamine H3R ligands and antiseizure agents","volume":"24","author":"Kuder","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2019.108775_bib54","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1016\/j.bmcl.2016.04.054","article-title":"Cholinesterase inhibitory activity of chlorophenoxy derivatives-Histamine H3 receptor ligands","volume":"26","author":"Lazewska","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2019.108775_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbr.2015.10.022","article-title":"The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats","volume":"297","author":"Khan","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2019.108775_bib56","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2174\/0929867013372274","article-title":"Azomethine prodrugs of (R)-alpha-methylhistamine, a highly potent and selective histamine H3-receptor agonist","volume":"8","author":"Krause","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cbi.2019.108775_bib57","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3389\/fphar.2017.00709","article-title":"The histamine H3 receptor antagonist E159 reverses memory deficits induced by dizocilpine in passive avoidance and novel object recognition paradigm in rats","volume":"8","author":"Alachkar","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108775_bib58","doi-asserted-by":"crossref","first-page":"13077","DOI":"10.1038\/s41598-018-31385-7","article-title":"The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism","volume":"8","author":"Eissa","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2019.108775_bib59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2147\/NDT.S193125","article-title":"Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats","volume":"15","author":"Alachkar","year":"2019","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.cbi.2019.108775_bib60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0166-4328(01)00216-9","article-title":"(3)-receptor antagonism improves memory retention and reverses the cognitive deficit induced by scopolamine in a two-trial place recognition task","volume":"124","author":"Orsetti","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2019.108775_bib61","first-page":"5499","article-title":"Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease","volume":"9","author":"Ojha","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.cbi.2019.108775_bib62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12868-016-0293-4","article-title":"Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone","volume":"17","author":"Javed","year":"2016","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.cbi.2019.108775_bib63","first-page":"50978","article-title":"Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice","author":"Angoa-Perez","year":"2013","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.cbi.2019.108775_bib64","article-title":"Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2019.108775_bib65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108775_bib66","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12974-016-0747-8","article-title":"Acute neuroinflammation provokes intracellular acidification in mouse hippocampus","volume":"13","author":"Tyrtyshnaia","year":"2016","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.cbi.2019.108775_bib67","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.4161\/cc.28401","article-title":"Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events","volume":"13","author":"McCloy","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cbi.2019.108775_bib68","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1476-5381.1996.tb16699.x","article-title":"Regulation of the human histamine H1 receptor stably expressed in Chinese hamster ovary cells","volume":"117","author":"Smit","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108775_bib69","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bcp.2009.05.015","article-title":"Histamine H(4) receptor-RGS fusion proteins expressed in Sf9 insect cells: a sensitive and reliable approach for the functional characterization of histamine H(4) receptor ligands","volume":"78","author":"Schneider","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108775_bib70","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108775_bib71","first-page":"64","article-title":"A\u00a0dopamine hypothesis of autism spectrum disorder","volume":"100","author":"Paval","year":"2017","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.cbi.2019.108775_bib72","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/npp.2013.274","article-title":"Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism","volume":"39","author":"Karvat","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cbi.2019.108775_bib73","doi-asserted-by":"crossref","first-page":"e1126","DOI":"10.1038\/tp.2017.87","article-title":"Altered expression of histamine signaling genes in autism spectrum disorder","volume":"7","author":"Wright","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.cbi.2019.108775_bib74","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-12-411546-0.00006-8","article-title":"Genetic susceptibility and neurotransmitters in tourette syndrome","volume":"112","author":"Paschou","year":"2013","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.cbi.2019.108775_bib75","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0447.2000.102005321.x","article-title":"Autism and Asperger syndrome: coexistence with other clinical disorders","volume":"102","author":"Gillberg","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.cbi.2019.108775_bib76","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/jmedgenet-2013-101637","article-title":"Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families","volume":"50","author":"Karagiannidis","year":"2013","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.cbi.2019.108775_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.290","article-title":"Histamine H3R receptor activation in the dorsal striatum triggers stereotypies in a mouse model of tic disorders","volume":"7","author":"Rapanelli","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.cbi.2019.108775_bib78","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neulet.2008.01.066","article-title":"Sensory gating in young children with autism: relation to age, IQ, and EEG gamma oscillations","volume":"434","author":"Orekhova","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cbi.2019.108775_bib79","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1073858403253552","article-title":"Disruption in the inhibitory architecture of the cell minicolumn: implications for autism","volume":"9","author":"Casanova","year":"2003","journal-title":"The Neuroscientist"},{"key":"10.1016\/j.cbi.2019.108775_bib80","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.cbi.2019.108775_bib81","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5607\/en.2015.24.4.285","article-title":"Exploring the validity of valproic acid animal model of autism","volume":"24","author":"Mabunga","year":"2015","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.cbi.2019.108775_bib82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cbi.2019.108775_bib83","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ntt.2012.07.006","article-title":"Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment","volume":"36","author":"Goines","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.cbi.2019.108775_bib84","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000492113","article-title":"Neuroimmune alterations in autism: a translational analysis focusing on the animal model of autism induced by prenatal exposure to valproic acid","volume":"25","author":"Deckmann","year":"2018","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.cbi.2019.108775_bib85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mcn.2012.10.003","article-title":"Peripheral and central inflammation in autism spectrum disorders","volume":"53","author":"Depino","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.cbi.2019.108775_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019488","article-title":"A\u00a0study of nuclear transcription factor-kappa B in childhood autism","volume":"6","author":"Naik","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2019.108775_bib87","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbi.2016.12.024","article-title":"Toll-like receptor 4 signaling is associated with upregulated NADPH oxidase expression in peripheral T cells of children with autism","volume":"61","author":"Nadeem","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cbi.2019.108775_bib88","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fpsyt.2011.00027","article-title":"Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation","volume":"2","author":"Young","year":"2011","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.cbi.2019.108775_bib89","article-title":"Methods to assess neuroinflammation","volume":"12","author":"Monnet-Tschudi","year":"2011","journal-title":"Curr Protoc Toxicol"},{"key":"10.1016\/j.cbi.2019.108775_bib90","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1017\/S1740925X12000142","article-title":"Evidence of microglial activation in autism and its possible role in brain underconnectivity","volume":"7","author":"Rodriguez","year":"2011","journal-title":"Neuron Glia Biol."},{"key":"10.1016\/j.cbi.2019.108775_bib91","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12506","article-title":"Autism-related behaviors in the cyclooxygenase-2-deficient mouse model","volume":"18","author":"Wong","year":"2019","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.cbi.2019.108775_bib92","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/mp.2016.103","article-title":"Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects","volume":"22","author":"Kim","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.cbi.2019.108775_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2015.06.005","article-title":"Microglia in the pathogenesis of autism spectrum disorders","volume":"100","author":"Koyama","year":"2015","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.cbi.2019.108775_bib94","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.biopsych.2010.05.024","article-title":"Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism","volume":"68","author":"Morgan","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cbi.2019.108775_bib95","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/02646830500381930","article-title":"Immunity, neuroglia and neuroinflammation in autism","volume":"17","author":"Pardo","year":"2005","journal-title":"Int. Rev. Psychiatry"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719306829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719306829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:47:13Z","timestamp":1762112833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719306829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":95,"alternative-id":["S0009279719306829"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108775","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108775"}}